Results 71 to 80 of about 2,449 (204)

Antithrombotic effect of Lonomia obliqua caterpillar bristle extract on experimental venous thrombosis

Brazilian Journal of Medical and Biological Research, 2002
The venom of Lonomia obliqua caterpillar may induce a hemorrhagic syndrome in humans, and blood incoagulability by afibrinogenemia when intravenously injected in laboratory animals. The possible antithrombotic and thrombolytic activities of L.
B.C. Prezoto, F.H.A. Maffei, L. Mattar, A.M. Chudzinski-Tavassi, P.R. Curi   +4 more
doaj   +1 more source

Bilateral leukocoria in infant with afibrinogenemia

Clinical Ophthalmology, 2008
M Necati Demir1, Mehmet Akif Acar1, Yusuf Ziya Aral2, Nurten Ünlü11Ankara Education and Research Hospital, Department of Ophthalmology, Ankara, Turkey; 2Aydin Menderes University, Faculty of Medicine, Department of Pediatric Hematology,
M Necati Demir, Mehmet Akif Acar, Yusuf Ziya Aral, Nurten Ünlü   +3 more
doaj  

Síntomas neurológicos focales transitorios por microsangrados cerebrales en hipofibrinogenemia congénita: reporte de un caso

Acta Neurológica Colombiana
Introducción: un espectro de enfermedad hemorrágica intracraneal se puede presentar con síntomas neurológicos focales transitorios; aunque las enfermedades congénitas del fibrinógeno son inusuales y rara vez se manifiestan de esta manera, a continuación
Mónica Ortiz Pereira, Camilo Andrés Romero Hernández, Luisa Fernanda Millán Suspe   +2 more
doaj   +1 more source

Diagnostic and management practices for inherited fibrinogen disorders: a nationwide survey of Italian Hemophilia Treatment Centers

Bleeding, Thrombosis and Vascular Biology
Background: inherited fibrinogen disorders are characterized by a spectrum of quantitative or qualitative fibrinogen deficiency associated with both a hemorrhagic and thrombotic risk.
Renato Marino, Silvia Linari, Marzia Leotta, Antonio Coppola, Chiara Biasoli, Maria Elisa Mancuso, Flora Peyvandi, Cristina Santoro, Ezio Zanon, Rita Carlotta Santoro   +9 more
doaj   +1 more source

Are all fibrinogen concentrates the same? The effects of two fibrinogen therapies in an afibrinogenemic patient and in a fibrinogen deficient plasma model. A clinical and laboratory case report

Frontiers in Medicine
The choice of treatments for inherited, or acquired, fibrinogen deficient states is expanding and there are now several fibrinogen concentrate therapies commercially available. Patients with the rare inherited bleeding disorder, afibrinogenemia, commonly
Soutiam Goodarzi, Soutiam Goodarzi, Jeries Abu-Hanna, Jeries Abu-Hanna, Sarah Harper, Dalia Khan, Gael Morrow, Gael Morrow, Nicola Curry, Nicola Curry   +9 more
doaj   +1 more source

Treatment of congenital fibrinogen deficiency: overview and recent findings

Vascular Health and Risk Management, 2009
Konstantinos Tziomalos, Sofia Vakalopoulou, Vassilios Perifanis, Vassilia GaripidouSecond Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, GreeceAbstract ...
Konstantinos Tziomalos, Sofia Vakalopoulou, Vassilios Perifanis, et al   +3 more
doaj  

Spontaneous vulvar hematoma as a rare manifestation of congenital hypofibrinogenemia. Case report

Case Reports, 2019
Introduction: Congenital fibrinogen disorders are rare conditions in which there are quantitative and qualitative alterations of factor I; the vast majority of patients are asymptomatic.
Sebastián Felipe Sierra-Umaña, Rafael García-Sanchez, Laura Camila Urrutia-Corredor, Jessica Tatiana Olarte-Luis, Dolli Yineth Cáceres-Galíndez   +4 more
doaj   +1 more source

Afibrinogenemia caused by a novel homozygous missense mutation, FGB p.Cys241Tyr, in a male patient with recurrent intracranial bleeding: case report and review of literature

Haemophilia, 2020
Congenital afibrinogenemia is a severe bleeding disorder, sometimes manifesting as thrombosis and/or pregnancy complications. Intracranial haemorrhage (ICH) constitutes the major cause of death in this disease.
J. Zdziarska, E. Wypasek, T. Iwaniec, Rui Vilar, M. Neerman-Arbez, A. Undas   +5 more
semanticscholar   +1 more source

Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population

Thrombosis Journal, 2017
Background Congenital afibrinogenemia (OMIM #202400) is a rare coagulation disorder that was first described in 1920. It is transmitted as an autosomal recessive trait that is characterized by absent levels of fibrinogen (factor I) in plasma ...
Arshi Naz, Arijit Biswas, Tehmina Nafees Khan, Anne Goodeve, Nisar Ahmed, Nazish Saqlain, Shariq Ahmed, Ikram Din Ujjan, Tahir S Shamsi, Johannes Oldenburg   +9 more
doaj   +1 more source

Manipulating the quality control pathway in transfected cells: low temperature allows rescue of secretion-defective fibrinogen mutants

Haematologica, 2008
Background Congenital afibrinogenemia is characterized by the absence of fibrinogen, a hexamer composed of two copies of three polypeptides, Aα. Bβ and γ. The disease is caused by mutations in one of the three fibrinogen-encoding genes, FGA, FGB and FGG.
Dung Vu, Corinne Di Sanza, Marguerite Neerman-Arbez   +2 more
doaj   +1 more source